Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NCM · Healthcare · Drug Manufacturers - Specialty & Generic
$2.78
-0.36%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.6M
Shares Outstanding
585K
Exchange
NCM
Currency
USD
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -3.9M | -2.3M | -2.8M | -2.2M |
| Net Income | -3.7M | -2.3M | -2.6M | -2.2M |
| Diluted EPS | $-3.29 | $-1.05 | $nan | $-0.43 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.3M | -5.9M | -7.7M | -11.9M |
| Net Income | -5.0M | -6.6M | -9.1M | -11.7M |
| Diluted EPS | $-126.00 | $-88.25 | $-82.60 | $-7.16 |